ABU DHABI / GULF TIME In a groundbreaking moment for luxury real estate, the German ...
Read More »Amgen fight over biotech drugs gets HC review
Bloomberg The US Supreme Court agreed to hear a dispute that could help clarify the steps needed to get low-cost alternatives to pricey biotechnology drugs on the market. It will be the first time the high court has agreed to interpret a 2010 provision of Obamacare that enabled the US Food and Drug Administration to approve biosimilars, which are ...
Read More »